Skip to content

Supplier News

Mylan launches pair of new generics in U.S.

Mylan launches pair of new generics in U.S.

Mylan N.V. this week introduced two new generic drugs in the U.S. market. On Monday, the company announced final Food and Drug Administration approval for dextroamphetamine sulfate extended-release capsules — in dosages of 5 mg, 10 mg and 15 mg — and finasteride tablets 1 mg.

CutisPharma appoints chief scientific officer

CutisPharma appoints chief scientific officer

Steven Dinh has joined CutisPharma as executive vice president and chief scientific officer. CutisPharma said Monday that Dinh will play a key role at the company, overseeing its efforts to develop its pipeline of drugs for New Drug Application (NDA) submission to the Food and Drug Administration.

Sanofi Pasteur begins shipment of flu vaccines

Sanofi Pasteur begins shipment of flu vaccines

Sanofi Pasteur is shipping its first doses of Fluzone vaccines for the 2016-17 flu season following their release by the Food and Drug Administration. Sanofi’s vaccines division said the shipment marks the start of more than 65 million doses of seasonal flu shots that it will deliver to U.S.

Ranir buys Rembrandt teeth whitening brand

Ranir buys Rembrandt teeth whitening brand

Ranir LLC, maker of the oral care brand Plackers, has acquired the Rembrandt teeth whitening brand from Johnson & Johnson Consumer Inc. Financial terms of the agreement weren’t disclosed. Ranir said Monday that the deal includes all intellectual property and rights to the Rembrandt brand.

Pane to become CEO of Coty

Pane to become CEO of Coty

Coty Inc. is promoting executive vice president Camillo Pane to chief executive officer. Coty said Thursday that Pane is slated to take the CEO reins after the company closes its deal to acquire Procter & Gamble Co.’s specialty beauty business.